These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 23933904)

  • 21. Patients with dyspepsia benefit from eradication of Helicobacter pylori if other organic causes for dyspepsia were carefully ruled out.
    Bojarski C; Epple HJ; Kirstein FW; Fromm M; Bisson S; Riecken EO; Schulzke JD
    Z Gastroenterol; 2000 Mar; 38(3):211-9. PubMed ID: 10768243
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of sequential and standard triple-drug regimen for Helicobacter pylori eradication: a 14-day, open-label, randomized, prospective, parallel-arm study in adult patients with nonulcer dyspepsia.
    Uygun A; Kadayifci A; Yesilova Z; Safali M; Ilgan S; Karaeren N
    Clin Ther; 2008 Mar; 30(3):528-34. PubMed ID: 18405790
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Helicobacter pylori: testing and treatment.
    Talley NJ; Li Z
    Expert Rev Gastroenterol Hepatol; 2007 Oct; 1(1):71-9. PubMed ID: 19072436
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Dyspepsia. Investigation and treatment].
    Schmidt VM; Bytzer P
    Ugeskr Laeger; 2001 Sep; 163(37):4990-4. PubMed ID: 11573369
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of the efficacy of 1-day high-dose quadruple therapy versus 7-day triple therapy for treatment of Helicobacter pylori infection.
    Zheng Q; Pan Y; Zhang L; Xiao SD
    Chin J Dig Dis; 2005; 6(4):202-5. PubMed ID: 16246231
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Guidelines in the medical treatment of Helicobacter pylori infection.
    Dzieniszewski J; Jarosz M
    J Physiol Pharmacol; 2006 Sep; 57 Suppl 3():143-54. PubMed ID: 17033112
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dyspepsia: organic versus functional.
    Oustamanolakis P; Tack J
    J Clin Gastroenterol; 2012 Mar; 46(3):175-90. PubMed ID: 22327302
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Accuracy of an enzyme immunoassay for the detection of Helicobacter pylori in stool specimens in the diagnosis of infection and posttreatment check-up.
    Forné M; Domínguez J; Fernández-Bañares F; Lite J; Esteve M; Galí N; Espinós JC; Quintana S; Viver JM
    Am J Gastroenterol; 2000 Sep; 95(9):2200-5. PubMed ID: 11007218
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictors of long-term outcome of functional dyspepsia and duodenal ulcer after successful Helicobacter pylori eradication--a 7-year follow-up study.
    Maconi G; Sainaghi M; Molteni M; Bosani M; Gallus S; Ricci G; Alvisi V; Porro GB
    Eur J Gastroenterol Hepatol; 2009 Apr; 21(4):387-93. PubMed ID: 19182682
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Helicobacter pylori infection in Turkish children: comparison of diagnostic tests, evaluation of eradication rate, and changes in symptoms after eradication.
    Ozçay F; Koçak N; Temizel IN; Demir H; Ozen H; Yüce A; Gürakan F
    Helicobacter; 2004 Jun; 9(3):242-8. PubMed ID: 15165260
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Diagnosis of Helicobacter pylori infections--how, when and in whom?].
    Wildner-Christensen M; Schaffalitzky de Muckadell OB
    Ugeskr Laeger; 2000 Jun; 162(26):3743-7. PubMed ID: 10925639
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quadruple therapy with medications containing either rufloxacin or furazolidone as a rescue regimen in the treatment of Helicobacter pylori-infected dyspepsia patients: a randomized pilot study.
    Gu LY; Lin WW; Lu H; Chen XY; Ge ZZ; Li XB
    Helicobacter; 2011 Aug; 16(4):284-8. PubMed ID: 21762267
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Artificial neural networks can classify uninvestigated patients with dyspepsia.
    Andriulli A; Grossi E; Buscema M; Pilotto A; Festa V; Perri F
    Eur J Gastroenterol Hepatol; 2007 Dec; 19(12):1055-8. PubMed ID: 17998828
    [TBL] [Abstract][Full Text] [Related]  

  • 34. One-day quadruple therapy compared with 7-day triple therapy for Helicobacter pylori infection.
    Lara LF; Cisneros G; Gurney M; Van Ness M; Jarjoura D; Moauro B; Polen A; Rutecki G; Whittier F
    Arch Intern Med; 2003 Sep; 163(17):2079-84. PubMed ID: 14504122
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical practice guideline on the management of patients with dyspepsia. Update 2012].
    Gisbert JP; Calvet X; Ferrándiz J; Mascort J; Alonso-Coello P; Marzo M;
    Gastroenterol Hepatol; 2012 Dec; 35(10):725.e1-38. PubMed ID: 23186826
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Should we take into account Helicobacter pylori infection in a patient with dyspeptic symptoms?].
    Jian R; Coffin B
    Gastroenterol Clin Biol; 2003 Mar; 27(3 Pt 2):432-9. PubMed ID: 12700500
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quadruple therapy with lactoferrin for Helicobacter pylori eradication: a randomised, multicentre study.
    Zullo A; De Francesco V; Scaccianoce G; Hassan C; Panarese A; Piglionica D; Panella C; Morini S; Ierardi E
    Dig Liver Dis; 2005 Jul; 37(7):496-500. PubMed ID: 15975536
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Helicobacter pylori eradication and standardized 3-month omeprazole therapy in functional dyspepsia.
    Koskenpato J; Farkkilä M; Sipponen P
    Am J Gastroenterol; 2001 Oct; 96(10):2866-72. PubMed ID: 11693319
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Helicobacter pylori and dyspepsia.
    Talley NJ
    Yale J Biol Med; 1999; 72(2-3):145-51. PubMed ID: 10780576
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Value of the "Test & Treat" Strategy for Uninvestigated Dyspepsia at Low Prevalence Rates of Helicobacter pylori in the Population.
    Agréus L; Talley NJ; Jones M
    Helicobacter; 2016 Jun; 21(3):186-91. PubMed ID: 26347458
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.